Evidence map›Paper›PMID 36980054›Full record

ArticleChildren (Basel, Switzerland)2023

Evaluation of Intravenous Immunoglobulin Administration for Hyperbilirubinemia in Newborn Infants with Hemolytic Disease.

Daniel R Mohan, Hannah Lu, Jacquelyn McClary, Jaime Marasch, Mary L Nock, Rita M Ryan

Open access · goldFull text read
PubMed Full text at PMC Publisher
In one paragraph

Article in Children (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
4.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Daniel R MohanDepartment of Pediatrics (Neonatology), Rainbow Babies and Children's Hospital, Cleveland, OH 44106, USA.
Hannah LuDepartment of Pharmacy, Rainbow Babies and Children's Hospital, Cleveland, OH 44106, USA.ORCID 0000-0003-2412-2558
Jacquelyn McClaryDepartment of Pharmacy, Rainbow Babies and Children's Hospital, Cleveland, OH 44106, USA.
Jaime MaraschDepartment of Pharmacy, Rainbow Babies and Children's Hospital, Cleveland, OH 44106, USA.
Mary L NockDepartment of Pediatrics (Neonatology), Rainbow Babies and Children's Hospital, Cleveland, OH 44106, USA.
Rita M RyanDepartment of Pediatrics (Neonatology), Rainbow Babies and Children's Hospital, Cleveland, OH 44106, USA.ORCID 0000-0002-4588-3412
Rainbow Babies & Children's Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The primary objective of this research was to evaluate the use of intravenous immunoglobulin (IVIG) in infants with hemolytic disease, to assess compliance with the American Academy of Pediatrics (AAP) guideline recommendations, and to review the data on which the guidelines were based. This retrospective study evaluated all infants in the NICU (neonatal intensive care unit) who received IVIG between January 2018 and December 2020 (

Indexed as

bilirubinCoombs testhyperbilirubinemiaintravenous immunoglobulinneonatal intensive care unitphototherapyretrospective studies

Identifiers

PMID36980054
PMCPMC10047662
OpenAlexW4323042919

What OpenQuestion holds

Textfull text, public
LicenceCC BY
reference markers read1
measurements read21
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.